Cylene Pharmaceuticals and TetraGene Enter Agreement for Quarfloxin and Anticancer Quadruplex Technologies

首页> 外文期刊>Journal of Engineering >Cylene Pharmaceuticals and TetraGene Enter Agreement for Quarfloxin and Anticancer Quadruplex Technologies

【24h】

Cylene Pharmaceuticals and TetraGene Enter Agreement for Quarfloxin and Anticancer Quadruplex Technologies

机译：Cylene Pharmaceuticals和TetraGene签订Quarfloxin和抗癌四链体技术协议

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

2013 MAR 20 (VerticalNews) -- By a News Reporter-Staff News Editor at Journal of Engineering --nCylene Pharmaceuticals, Inc. announced that it has entered into an exclusive, worldwide Option andnLicense Agreement that will allow TetraGene LLC to advance the development of Quarfloxin andnCylene's associated anticancer quadruplex-targeting technologies. Cylene will receive an upfront fee, asnwell as potential milestone payments and royalties on product sales for the exclusive license.

机译：2013年3月20日（VerticalNews）-工程杂志上的新闻记者-工作人员新闻编辑-nCylene Pharmaceuticals，Inc.宣布已签署一项独家的，全球性的选择权和nLicense协议，该协议将使TetraGene LLC能够推动开发Quarfloxin和nCylene的相关抗癌四链体靶向技术。对于独家授权，Cylene将收取预付费用，以及潜在的里程碑付款和产品销售的特许权使用费。

著录项

来源
《Journal of Engineering 》 |2013年第12期| 1-1| 共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Cylene Pharmaceuticals Inc.; Technology.;

机译：Cylene Pharmaceuticals Inc .;技术。;

相似文献

外文文献
中文文献
专利

1. Celsion Corporation and Zhejiang Hisun Pharmaceutical Company enter into technology development agreement for ThermoDox~R for the Greater China Territory [J] . Asia-Pacific Biotech News . 2013 ,第3期

机译：Celsion公司与浙江海正药业有限公司就大中华地区的ThermoDox〜R签订了技术开发协议
2. Suzhou Amerigen Pharmaceuticals Co., Enters Into a Marketing and Distribution Agreement with Sinochem Jiangsu Pharmaceutical Co., Ltd. [J] . Asia-Pacific Biotech News . 2013 ,第10a11期

机译：苏州Amerigen制药有限公司与中化江苏制药有限公司签订了营销和分销协议。
3. ASLAN Pharmaceuticals and A*STAR Enter RON Antibody Licensing and Research Collaboration Agreement [J] . Asia-Pacific Biotech News . 2016 ,第10期

机译：ASLAN Pharmaceuticals与A * STAR签订RON抗体许可和研究合作协议
4. Anticancer activity of platinum(Ⅱ) complex as G-quadruplex DNA Binders [C] . Qipin Qin, Yulan Li, Yancheng Liu, International Conference on Chemical Engineering and Advanced Materials . 2013

机译：铂（Ⅱ）复合物作为G-QuadrepleDNA粘合剂的抗癌活性
5. Development of G-quadruplex stabilizers as anticancer drug therapy and selective agonists of the human oxytocin receptor as a therapeutic tool for neuropsychiatric disorders. [D] . Sassano, Maria Florencia. 2009

机译：G-四链体稳定剂作为抗癌药物疗法的发展以及人类催产素受体的选择性激动剂作为神经精神疾病的治疗工具的发展。
6. Correction to article ‘G-quadruplex–R-loop interactions and the mechanism of anticancer G-quadruplex binders’ [O] . Giulia Miglietta, Marco Russo, Giovanni Capranico 2021

机译：对物品G-Quadruplex-R环相互作用的校正和抗癌G-Quadruplex粘合剂的机制
7. Proposal for a Council Regulation (EC) concerning the export of certain ECSC and EC steel products from certain third countries to the European Communities; Proposal for aCouncil Decision on the position to be taken by the Community within the Association Council established by the Europe Agreement between the European Communities andtheir Member States, of the one part, and the Republic of Bulgaria, of the other part, which entered into force on 1 February 1995, concerning the export of certain steel products from the Republic of Bulgaria to the European Communities; Proposal for a Council Decision on the position to be taken by the Community within the Association Council established by the Europe Agreement between the European Communities and their Member States, of the one part, and the Czech Republic, of the other part, which entered into force on 1 February 1995, concerning the export of certain steel products from the Czech Republic to the European Communities; Proposal for a Council Decision on the position to be taken by the Community within the Association Council established by the Europe Agreement between the European Communities and their Member States, of the one part, and Romania, of the other part, which entered into force on 1 February 1995, concerning the export of certain steel products from Romania to the European Communities; Proposal for a Council Decision on the position to be taken by the Community within the Association Council established by the Europe Agreement between the European Communities and their Member States, of the one part, and the Slovak Republic, of the other part, which entered into force on 1 February 1995, concerning the export of certain steel products from the Slovak Republic to the European Communities (presented by the Commission). COM (95) 574 final, 27 November 1995 [O] . 1995

机译：关于向某些第三国向欧洲共同体出口某些ECsC和EC钢产品的理事会条例（EC）的提案;建议a理事会关于欧洲共同体与欧洲共同体之间协会理事会在协会理事会中所采取立场的决定1995年2月1日生效的另一部分的成员国和保加利亚共和国，其中涉及从保加利亚共和国向欧洲共同体出口某些钢铁产品;关于欧洲共同体与其成员国之间欧洲协定所建立的协会理事会共同立场的决定提案，其中一部分与捷克共和国签署的另一部分1995年2月1日，关于从捷克共和国向欧洲共同体出口某些钢铁产品;关于欧洲共同体与其成员国之间欧洲协定所建立的协会理事会共同立场的决定的建议，另一部分是罗马尼亚的另一部分，该协定已经生效。 1995年2月1日，关于从罗马尼亚向欧洲共同体出口某些钢铁产品;关于欧洲共同体与其成员国之间欧洲协定所建立的协会理事会共同立场的决定的建议，另一部分是斯洛伐克共和国，另一部分是1995年2月1日，关于从斯洛伐克共和国向欧洲共同体出口某些钢铁产品（由委员会提交）。 COm（95）574 final，1995年11月27日
8. Guidance for Industry: S9 Nonclinical Evaluation for Anticancer Pharmaceuticals [R] . 2010

机译：行业指南：s9抗癌药物的非临床评估

Cylene Pharmaceuticals and TetraGene Enter Agreement for Quarfloxin and Anticancer Quadruplex Technologies

摘要

著录项

相似文献

相关主题

期刊订阅